Impact on Medical Cost, Cumulative Survival, and Cost-Effectiveness of Adding Rituximab to First-Line Chemotherapy for Follicular Lymphoma in Elderly Patients: An Observational Cohort Study Based on SEER-Medicare.

Impact on Medical Cost, Cumulative Survival, and Cost-Effectiveness of Adding Rituximab to First-Line Chemotherapy for Follicular Lymphoma in Elderly Patients: An Observational Cohort Study Based on SEER-Medicare.

Rituximab improves survival in follicular lymphoma (FL), but is considerably more expensive than conventional chemotherapy. We estimated the total direct medical costs, cumulative survival, and cost-effectiveness of adding rituximab to first-line chemotherapy for FL, based on a single source of data...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Griffiths, R, Gleeson, M, Mikhael, J, Danese, MD
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	2012

समान संसाधन

Comparative effectiveness and cost of adding rituximab to first-line chemotherapy for elderly patients diagnosed with diffuse large B-cell lymphoma
द्वारा: Griffiths, R, और अन्य
प्रकाशित: (2012)

Comparative effectiveness and cost of adding rituximab to first-line chemotherapy for elderly patients diagnosed with diffuse large B-cell lymphoma.
द्वारा: Griffiths, R, और अन्य
प्रकाशित: (2012)

Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphoma.
द्वारा: Griffiths, R, और अन्य
प्रकाशित: (2011)

Inverse probability weighted least squares regression in the analysis of time-censored cost data: an evaluation of the approach using SEER-Medicare.
द्वारा: Griffiths, R, और अन्य
प्रकाशित: (2012)

Survival in elderly follicular lymphoma patients who receive frontline chemo-immunotherapy.
द्वारा: Griffiths, R, और अन्य
प्रकाशित: (2010)

Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare.
द्वारा: Griffiths, R, और अन्य
प्रकाशित: (2012)

Rituximab maintenance therapy of follicular lymphoma in clinical practice
द्वारा: Ulrich Dührsen, और अन्य
प्रकाशित: (2018-07-01)

An observational study of outcomes after initial infused therapy in Medicare patients diagnosed with chronic lymphocytic leukemia.
द्वारा: Danese, MD, और अन्य
प्रकाशित: (2011)

Rituximab maintenance therapy: a step forward in follicular lymphoma
द्वारा: Marinus H.J. van Oers
प्रकाशित: (2007-06-01)

Rituximab Maintenance Strategy in Advanced Follicular Lymphoma: Facts and Controversies
द्वारा: Vibor Milunović, और अन्य
प्रकाशित: (2017-01-01)

Second-line therapy in diffuse large B-cell lymphoma (DLBCL): treatment patterns and outcomes in older patients receiving outpatient chemotherapy.
द्वारा: Danese, MD, और अन्य
प्रकाशित: (2016)

Life-threatening Pneumocystis jiroveci Pneumonia with Cytomegalovirus Coinfection in a Follicular Lymphoma Patient During Rituximab-based Chemotherapy
द्वारा: Mu-Chun Yang, और अन्य
प्रकाशित: (2024-01-01)

Symptomatic Follicular Lymphoma: Complete Remission After Chemoimmunotherapy with Bendamustine–Rituximab
द्वारा: Wulyo Rajabto, और अन्य
प्रकाशित: (2024-04-01)

Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma
द्वारा: Klaus Herfarth, और अन्य
प्रकाशित: (2018-12-01)

FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
द्वारा: Alessia Castellino, और अन्य
प्रकाशित: (2017-01-01)

Managing Follicular Lymphoma in the Elderly Population
द्वारा: Jiao Jie Cherie Tan, और अन्य
प्रकाशित: (2023-01-01)

Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response
द्वारा: Ulrich Jäger, और अन्य
प्रकाशित: (2012-09-01)

Rituximab and dose dense chemotherapy in primary breast lymphoma
द्वारा: Agustin Avilés, और अन्य
प्रकाशित: (2007-08-01)

Comparative Costs to Medicare and Medicare Beneficiaries of Alternative AF Stroke Risk Reduction Strategies
द्वारा: Reddy VY, और अन्य
प्रकाशित: (2024-02-01)

S206: OBINUTUZUMAB PLUS CHEMOTHERAPY DEMONSTRATES LONG-TERM BENEFIT OVER RITUXIMAB PLUS CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: FINAL ANALYSIS OF THE GALLIUM STUDY
द्वारा: W. Townsend, और अन्य
प्रकाशित: (2022-06-01)

Cost implications to Medicare of recombinant erythropoietin therapy for the anemia of end-stage renal disease.
द्वारा: Powe, N, और अन्य
प्रकाशित: (1993)

Treatment Patterns and Health Care Costs in Commercially Insured Patients with Follicular Lymphoma
द्वारा: Nathan H. Fowler, और अन्य
प्रकाशित: (2020-09-01)

Cumulative reproduction and survival costs in female red deer
द्वारा: Moyes, K, और अन्य
प्रकाशित: (2006)

Survival outcomes in an older US population with advanced melanoma and central nervous system metastases: SEER‐Medicare analysis
द्वारा: Natalia Sadetsky, और अन्य
प्रकाशित: (2020-09-01)

Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)
द्वारा: Griffiths, R, और अन्य
प्रकाशित: (2010)

P1738: A SEER-MEDICARE ANALYSIS OF THE ECONOMIC BURDEN AMONG ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH HYPOMETHYLATING AGENTS
द्वारा: A. McBride, और अन्य
प्रकाशित: (2022-06-01)

Outcomes of the transformation of follicular lymphoma to diffuse large B‐cell lymphoma in the rituximab era: A population‐based study
द्वारा: Wenshuai Zheng, और अन्य
प्रकाशित: (2024-04-01)

PB2275: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB PLUS CHEMOTHERAPY VERSUS RITUXIMAB PLUS CHEMOTHERAPY IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (OLYMPIA-2)
द्वारा: Silvana Novelli, और अन्य
प्रकाशित: (2023-08-01)

Efficacy, safety and cost-effectiveness of obinutuzumab in patients with follicular lymphoma: a rapid review
द्वारा: Chao Wang, और अन्य
प्रकाशित: (2025-01-01)

Granulocyte-colony stimulating factor use and medical costs after initial adjuvant chemotherapy in older patients with early-stage breast cancer.
द्वारा: Griffiths, R, और अन्य
प्रकाशित: (2012)

Up-front rituximab maintenance improves outcome in patients with follicular lymphoma: a collaborative Nordic study
द्वारा: C. Madsen, और अन्य
प्रकाशित: (2018-07-01)

Follicular lymphoma
द्वारा: Ellen Leich, (Coordinating Author)
प्रकाशित: (2019-06-01)

Subcutaneous rituximab in patients with diffuse large B cell lymphoma and follicular lymphoma: Final results of the non‐interventional study MabSCale
द्वारा: Jan Dürig, और अन्य
प्रकाशित: (2023-02-01)

Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis
द्वारा: Sikander Ailawadhi, और अन्य
प्रकाशित: (2019-10-01)

A Case of Fulminant Hepatitis due to Echovirus 9 in a Patient on Maintenance Rituximab Therapy for Follicular Lymphoma
द्वारा: Ceri Morgan, और अन्य
प्रकाशित: (2015-01-01)

Racial and Ethnic Disparities in the Burden and Cost of Diabetes for US Medicare Beneficiaries
द्वारा: Namino M. Glantz, और अन्य
प्रकाशित: (2019-05-01)

Lenalidomide Consolidation Added to Rituximab Maintenance Therapy in Patients Remaining PET Positive After Treatment for Relapsed Follicular Lymphoma: A Phase 2 Australasian Leukaemia & Lymphoma Group NHL26 Study
द्वारा: Judith Trotman, और अन्य
प्रकाशित: (2023-03-01)

Rituximab maintenance improves overall survival in follicular lymphoma: A retrospective nationwide real‐world analysis from Taiwan Cancer Registry Database
द्वारा: Huai‐Hsuan Huang, और अन्य
प्रकाशित: (2018-08-01)

P1103: INMIND: A PHASE 3 STUDY OF TAFASITAMAB PLUS LENALIDOMIDE AND RITUXIMAB VERSUS PLACEBO PLUS LENALIDOMIDE AND RITUXIMAB FOR RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL) OR MARGINAL ZONE LYMPHOMA (MZL)
द्वारा: L. H. Sehn, और अन्य
प्रकाशित: (2022-06-01)

Follicular lymphoma genomics
द्वारा: Emil Kumar, और अन्य
प्रकाशित: (2019-06-01)